Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity

López de Padilla, 2007, Involvement of dendritic cells in autoimmune diseases in children, Pediatr Rheumatol Online J, 11, 5 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) report. Understanding Autoimmune Diseases. National Institutes of Health (NIH). 2012; 1–3 [NIH Publication No. 11-7582]. El-Sayed, 2008, Correlative study of plasma TH1/TH2 cytokines levels in patients with systemic lupus erythematosus with SLEDAI, Egypt Dermatol Online J, 4, 3 Hogan, 2010, Role of B cells in rheumatic autoimmune disease, Arthritis J, 3, 32, 10.2174/1876539401003010032 Shah, 2010, Dysregulated balance of TH17 and TH1 cells in systemic lupus erythematosus, Arthritis Res Ther, 12, 10.1186/ar2964 Avrămescu, 2010, Cytokine panel and histopathological aspects in the systemic lupus erythematosus, Rom J Morphol Embryol, 51, 633 Okamoto, 2011, Regulatory T-cell-associated cytokines in systemic lupus erythematosus, J Biomed Biotechnol, 463412, 1, 10.1155/2011/463412 Viallard, 1999, TH1 (IL-2, interferon-gamma (IFN-g)) and TH2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE), Clin Exp Immunol, 115, 189, 10.1046/j.1365-2249.1999.00766.x Vukmanovic-Stejic, 2000, Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes, Blood, 95, 231, 10.1182/blood.V95.1.231 Kleczynska, 2011, Imbalance between TH17 and regulatory T-cells in systemic lupus erythematosus, Folia Histochem Cytobiol, 49, 646, 10.5603/FHC.2011.0088 Qu, 2013, Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases, Clin Dev Immunol, 2013, 968549, 10.1155/2013/968549 Kolls, 2004, Interleukin-17 family members and inflammation, Immunity, 21, 467, 10.1016/j.immuni.2004.08.018 Murphy, 2003, Divergent pro and anti inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation, J Exp Med, 198, 1951, 10.1084/jem.20030896 Dolff, 2011, Disturbed TH1, TH2, TH17 and Treg balance in patients with systemic lupus erythematosus, Clin Immunol, 141, 197, 10.1016/j.clim.2011.08.005 Kuhn, 2009, CD4 (+) CD25 (+) regulatory T cells in human lupus erythematosus, Arch Dermatol Res, 301, 71, 10.1007/s00403-008-0891-9 Roncarolo, 2006, Interleukin-10-secreting type 1 regulatory T cells in rodents and humans, Immunol Rev, 212, 28, 10.1111/j.0105-2896.2006.00420.x Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum, 35, 630, 10.1002/art.1780350606 Chun, 2007, Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus, J Clin Immunol, 27, 461, 10.1007/s10875-007-9104-0 Mok, 2010, The relation of interleukin 17 (IL-17) and IL-23 to TH1/TH2 cytokines and disease activity in systemic lupus erythematosus, J Rheumatol, 37, 2046, 10.3899/jrheum.100293 Aletaha, 2010, 2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 Talaat, 2010, Soluble angiogenesis factors in sera of Egyptian patients with hepatitis C virus infection: correlation with disease severity, Viral Immunol, 23, 151, 10.1089/vim.2009.0089 Talaat, 2007, Cytokine secretion profile associated with periportal fibrosis in S. mansoni-infected Egyptian patients, Parasitol Res, 101, 289, 10.1007/s00436-007-0478-y Akahoshi, 1999, TH1/TH2 balance of peripheral T helper cells in systemic lupus erythematosus, Arthritis Rheum, 42, 1644, 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L Hagiwara, 1996, Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-gamma-secreting cells in the peripheral blood, Arthritis Rheum, 39, 379, 10.1002/art.1780390305 Sultan, 2010, Assessment of Proinflammatory TH1 Cytokines (IL18-IFN γ) and TH2 Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Arthritis and Systemic Sclerosis), Egypt J Hosp Med, 38, 1, 10.21608/ejhm.2010.17362 Arora, 2012, Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects, Lupus, 21, 596, 10.1177/0961203311434937 Lee, 2009, Anti-ribosomal phosphoprotein autoantibody triggers interleukin-10 overproduction via phosphatidylinositol 3-kinase-dependent signalling pathways in lipopolysaccharide-activated macrophages, Immunology, 127, 91, 10.1111/j.1365-2567.2008.02925.x Mellor-Pita, 2009, Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus, Cytometry B Clin Cytom, 76, 261, 10.1002/cyto.b.20468 Liorente, 1994, In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren’s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity, Arthritis Rheum, 37, 1647, 10.1002/art.1780371114 Kalampokis, 2013, IL-10-producing regulatory B cells (B10 cells) in autoimmune disease, Arthritis Res Ther, 15, S1, 10.1186/ar3907 Su, 2012, Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE, J Biomed Biotechnol, 2012, 347141, 10.1155/2012/347141 Park, 1998, Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus, Clin Exp Rheumatol, 16, 283 Nagafuchi, 1993, Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus, J Immunol, 151, 6525, 10.4049/jimmunol.151.11.6525 Crispin, 2008, Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys, J Immunol, 181, 8761, 10.4049/jimmunol.181.12.8761 Damsker, 2010, TH1 and TH17 cells: adversaries and collaborators, Ann N Y Acad Sci, 1183, 211, 10.1111/j.1749-6632.2009.05133.x Capper, 2004, Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?, Clin Exp Immunol, 138, 348, 10.1111/j.1365-2249.2004.02607.x Dai, 2007, Essential roles of IL-12 and dendritic cells but not IL-23 and macrophages in lupus-like diseases initiated by cell surface HSP gp96, Eur J Immunol, 37, 706, 10.1002/eji.200636643 Gee, 2009, The IL-12 family of cytokines in infection, inflammation and autoimmune disorders, Inflamm Allergy Drug Targets, 8, 40, 10.2174/187152809787582507 Eisenstein, 2009, The Treg/TH17 cell balance: a new paradigm for autoimmunity, Pediatr Res, 65, 26R, 10.1203/PDR.0b013e31819e76c7 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Becker-Merok, 2010, Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease, J Rheumatol, 37, 2039, 10.3899/jrheum.100180 Jäger, 2010, Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation, Scand J Immunol, 72, 173, 10.1111/j.1365-3083.2010.02432.x Ma, 2010, The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients, Clin Rheumatol, 29, 1251, 10.1007/s10067-010-1510-7 Wong, 2008, Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity, Clin Immunol, 127, 385, 10.1016/j.clim.2008.01.019 Goronzy, 2001, T cell homeostasis and autoreactivity in rheumatoid arthritis, Curr Dir Autoimmun, 3, 112, 10.1159/000060516 Cascão, 2010, Identification of a cytokine network sustaining neutrophil and TH17 activation in untreated early rheumatoid arthritis, Arthritis Res Ther, 12, R196, 10.1186/ar3168 Sivalingam, 2007, In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis, Ann Acad Med Singapore, 36, 96, 10.47102/annals-acadmedsg.V36N2p96 Mieliauskaite, 2008, Plasma levels of transforming growth factor β1 (TGF-β1) in patients with rheumatoid arthritis and Sjögren’s syndrome, Acta medica lituanica, 15, 211 Chung, 2011, The correlation between increased plasma concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients, Yonsei Med J, 52, 113, 10.3349/ymj.2011.52.1.113 Knudsen, 2008, Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis, Biomarkers, 13, 59, 10.1080/13547500701615017 Metawi, 2011, Plasma and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA, Clin Rheumatol, 30, 1201, 10.1007/s10067-011-1737-y